I tried eating normally at first three regular meals
Several GLP-1 agonists have FDA approval for other indications that may overlap with BED patient populations: Semaglutide (Wegovy) and liraglutide (Saxenda) are approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity Semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro) are approved for type 2 diabetes management Tirzepatide (Zepbound) is approved for chronic weight management When clinicians prescribe GLP-1 agonists for BED, this constitutes off-label use a legal and common practice in medicine when evidence suggests potential benefit and approved treatments are inadequate
Long-Term Gastroparesis While GLP-1 inhibitors can slow stomach emptying, this effect does not necessarily indicate long-term gastroparesis
Heres what might be happening: Proper hydration is about balancing your fluid and mineral intake, not just chugging plain water
proceed with caution) Research chemical vendors (not recommended
For compound-specific guides on the dual and single agonists, see the tirzepatide protocol and semaglutide protocol